Literature DB >> 31099333

The effects of magnesium supplementation on gene expression related to inflammatory markers, vascular endothelial growth factor, and pregnancy outcomes in patients with gestational diabetes.

Shahnaz Ahmadi1, Maryam Naderifar1, Mansooreh Samimi2, Naghmeh Mirhosseini3, Elahe Amirani4, Esmat Aghadavod4, Zatollah Asemi4.   

Abstract

Magnesium has been introduced as one of the micronutrients with several metabolic benefits, mainly anti-inflammatory properties. The aim of this study was to evaluate the effects of magnesium supplementation on gene expression of inflammatory markers, vascular endothelial growth factor (VEGF), and pregnancy outcomes in women diagnosed with gestational diabetes mellitus (GDM). This randomized, double-blinded, placebo-controlled trial was conducted among 36 women, aged 18-40 years old, diagnosed with GDM. Study participants were randomly allocated into two groups to receive either 250 mg/day magnesium oxide (n = 18) or placebo (n = 18) for six weeks. Gene expression related to inflammatory markers and VEGF was assessed using peripheral blood mononuclear cells (PBMCs) of women with GDM, via RT-PCR method. Quantitative results of RT-PCR demonstrated that magnesium supplementation downregulated gene expression levels of interleukin-8 (IL-8) (P = 0.03) and tumor necrosis factor-α (TNF-α) (P = 0.006) and upregulated gene expression levels of transforming growth factor beta (TGF-β) (P = 0.03) in PBMCs of women with GDM, compared with placebo. Magnesium supplementation did not significantly affect gene expression of IL-1 and vascular endothelial growth factor. Additionally, magnesium administration resulted in a lower incidence of newborn hyperbilirubinemia (11.1% versus 44.4%, P = 0.02) and newborn hospitalization (11.1% versus 44.4%, P = 0.02) compared with placebo. Overall, magnesium supplementation for six weeks significantly decreased gene expression levels of IL-8 and TNF-α, and increased TGF-β in women with GDM. Therefore, magnesium supplementation might be recommended to decrease metabolic complications in women with GDM, due to its beneficial effects on gene expression of inflammatory markers.

Entities:  

Keywords:  gene expression; gestational diabetes; inflammation; magnesium; pregnancy outcomes

Mesh:

Substances:

Year:  2018        PMID: 31099333     DOI: 10.1684/mrh.2019.0446

Source DB:  PubMed          Journal:  Magnes Res        ISSN: 0953-1424            Impact factor:   1.115


  2 in total

1.  The Relation Between Trace Element Status (Zinc, Copper, Magnesium) and Clinical Outcomes in COVID-19 Infection During Pregnancy.

Authors:  Ali Taner Anuk; Naci Polat; Sevginur Akdas; Seyit Ahmet Erol; Atakan Tanacan; Derya Biriken; Huseyin Levent Keskin; Ozlem Moraloglu Tekin; Nuray Yazihan; Dilek Sahin
Journal:  Biol Trace Elem Res       Date:  2020-11-24       Impact factor: 4.081

Review 2.  The Impact of Nutritional Supplementation During Pregnancy on the Incidence of Gestational Diabetes and Glycaemia Control.

Authors:  Ibrahim Ibrahim; Mohammed Bashir; Parul Singh; Souhaila Al Khodor; Hala Abdullahi
Journal:  Front Nutr       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.